• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转谷氨酰胺酶 2 的表达增加驱动肾癌细胞的糖酵解代谢。

Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.

机构信息

Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang, Kyonggi-do, Republic of Korea.

出版信息

Amino Acids. 2014 Jun;46(6):1527-36. doi: 10.1007/s00726-014-1714-2. Epub 2014 Mar 19.

DOI:10.1007/s00726-014-1714-2
PMID:24643363
Abstract

Transglutaminase 2 (TGase 2) expression and glycolysis are increased in most renal cell carcinoma (RCC) cell lines compared to the HEK293 kidney cell line. Although increased glycolysis and altered tricarboxylic acid cycle are common in RCC, the detailed mechanism by which this phenomenon occurs remains to be elucidated. In the present study, TGase 2 siRNA treatment lowered glucose consumption and lactate levels by about 20-30 % in RCC cells; conversely, high expression of TGase 2 increased glucose consumption and lactate production together with decreased mitochondrial aconitase (Aco 2) levels. In addition, TGase 2 siRNA increased mitochondrial membrane potential and ATP levels by about 20-30 % and restored Aco 2 levels in RCC cells. Similarly, Aco 2 levels and ATP production decreased significantly upon TGase 2 overexpression in HEK293 cells. Therefore, TGase 2 leads to depletion of Aco 2, which promotes glycolytic metabolism in RCC cells.

摘要

转谷氨酰胺酶 2(TGase 2)的表达和糖酵解在大多数肾细胞癌(RCC)细胞系中比 HEK293 肾细胞系增加。尽管糖酵解增加和三羧酸循环改变在 RCC 中很常见,但这种现象发生的详细机制仍有待阐明。在本研究中,TGase 2 siRNA 处理使 RCC 细胞中的葡萄糖消耗和乳酸水平降低约 20-30%;相反,高表达的 TGase 2 增加了葡萄糖消耗和乳酸生成,同时降低了线粒体顺乌头酸酶(Aco 2)水平。此外,TGase 2 siRNA 使 RCC 细胞中的线粒体膜电位和 ATP 水平增加约 20-30%,并恢复了 Aco 2 水平。同样,在 HEK293 细胞中转染 TGase 2 过表达后,Aco 2 水平和 ATP 产生显著下降。因此,TGase 2 导致 Aco 2 的耗竭,从而促进了 RCC 细胞的糖酵解代谢。

相似文献

1
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.转谷氨酰胺酶 2 的表达增加驱动肾癌细胞的糖酵解代谢。
Amino Acids. 2014 Jun;46(6):1527-36. doi: 10.1007/s00726-014-1714-2. Epub 2014 Mar 19.
2
Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus.转谷氨酰胺酶 2 的别构抑制位点在 N 端被揭示。
Amino Acids. 2018 Nov;50(11):1583-1594. doi: 10.1007/s00726-018-2635-2. Epub 2018 Aug 14.
3
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.转谷氨酰胺酶 2 抑制被发现可诱导肾细胞癌中 p53 介导的细胞凋亡。
FASEB J. 2013 Sep;27(9):3487-95. doi: 10.1096/fj.12-224220. Epub 2013 May 23.
4
Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.转谷氨酰胺酶 2 通过激活炎症信号通路重编程乳腺上皮细胞的糖代谢。
Int J Cancer. 2014 Jun 15;134(12):2798-807. doi: 10.1002/ijc.28623. Epub 2014 Jan 30.
5
Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.肾细胞癌通过转谷氨酰胺酶2介导的自噬逃避因p53缺失导致的死亡。
Cell Death Dis. 2016 Mar 31;7(3):e2163. doi: 10.1038/cddis.2016.14.
6
Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.癌细胞通过蛋白交联使抑癌基因 von Hippel-Lindau 耗竭从而促进存活。
Oncogene. 2011 Dec 1;30(48):4780-90. doi: 10.1038/onc.2011.183. Epub 2011 May 30.
7
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.转谷氨酰胺酶 2 抑制剂可消除异种移植模型中的肾细胞癌。
J Cancer Res Clin Oncol. 2014 May;140(5):757-67. doi: 10.1007/s00432-014-1623-5. Epub 2014 Mar 8.
8
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.抑制转谷氨酰胺酶 2 而不是 MDM2 对肾细胞癌具有显著的治疗效果。
Cells. 2020 Jun 16;9(6):1475. doi: 10.3390/cells9061475.
9
Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.激活蛋白激酶 C 受体 1 蛋白受抑癌基因 von Hippel-Lindau 调控在 IGF-I 诱导的肾癌细胞侵袭中的作用。
Oncogene. 2011 Feb 3;30(5):535-47. doi: 10.1038/onc.2010.427. Epub 2010 Sep 27.
10
Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.1型膜基质金属蛋白酶介导希佩尔·林道肾癌细胞的肿瘤细胞侵袭。
Mol Cancer. 2006 Dec 1;5:66. doi: 10.1186/1476-4598-5-66.

引用本文的文献

1
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis.PI3K/AKT/mTOR 失调与肾癌代谢途径重编程:与 VHL/HIF 轴的串扰。
Int J Mol Sci. 2023 May 7;24(9):8391. doi: 10.3390/ijms24098391.
2
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K Channel in Breast Cancer.一种多学科方法揭示了转谷氨酰胺酶2与乳腺癌中Kv10.1电压依赖性钾通道之间的联系。
Cancers (Basel). 2022 Dec 28;15(1):178. doi: 10.3390/cancers15010178.
3
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.
转谷氨酰胺酶2:肾细胞癌致癌介质中的大师
Med Sci (Basel). 2019 Feb 6;7(2):24. doi: 10.3390/medsci7020024.
4
Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target.转谷氨酰胺酶2作为一种癌细胞存活因子和治疗靶点而备受关注。
Mol Carcinog. 2019 Jun;58(6):837-853. doi: 10.1002/mc.22986. Epub 2019 Mar 28.
5
Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia.活化的肝星状细胞通过转谷氨酰胺酶2诱导的假性缺氧促进肝细胞癌的上皮-间质转化。
Commun Biol. 2018 Oct 25;1:168. doi: 10.1038/s42003-018-0177-5. eCollection 2018.
6
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds.转谷氨酰胺酶2抑制剂作为药物先导化合物开发的新见解
Med Sci (Basel). 2018 Oct 8;6(4):87. doi: 10.3390/medsci6040087.
7
Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.转谷氨酰胺酶2在实验性肺动脉高压中肺和心脏组织重塑中的作用
Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L752-L762. doi: 10.1152/ajplung.00170.2017. Epub 2017 Aug 3.
8
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.在肾细胞癌初始肿瘤发生过程中转谷氨酰胺酶2表达水平升高预示着转移风险增加、无病生存期和癌症特异性生存期缩短。
World J Urol. 2015 Oct;33(10):1553-60. doi: 10.1007/s00345-014-1462-7. Epub 2014 Dec 17.